MEGAN SNYDER: Open Payments
NPI 1497228274 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$514 in 20 payments from 6 companies in 2025. Trend: 2023 $491 · 2024 $370 · 2025 $514
Food & beverage: $514
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $204 |
| Sumitomo Pharma America, Inc. | 9 | $192 |
| Medtronic, Inc. | 2 | $47 |
| PROGENICS PHARMACEUTICALS, INC. | 2 | $39 |
| PFIZER INC. | 1 | $18 |
| TOLMAR, INC. | 1 | $14 |
Products named: Nubeqa, GEMTESA, INTERSTIM, PYLARIFY, ORGOVYX, XTANDI, JATENZO.
Industry payments across IN — which companies pay providers there.
